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Abstract
On April 18, 2007 an international meeting on Pathophysiology of Ageing, Longevity and Age-
Related Diseases was held in Palermo, Italy. Several interesting topics on Cancer,
Immunosenescence, Age-related inflammatory diseases and longevity were discussed. In this report
we summarize the most important issues. However, ageing must be considered an unavoidable end
point of the life history of each individual, nevertheless the increasing knowledge on ageing
mechanisms, allows envisaging many different strategies to cope with, and delay it. So, a better
understanding of pathophysiology of ageing and age-related disease is essential for giving everybody
a reasonable chance for living a long and enjoyable final part of the life.
Background
On April 18, 2007 an international meeting on Patho-
physiology of Ageing, Longevity and Age-Related Diseases
was held in Palermo, Italy. Several interesting topics were
discussed. Here we summarize the most important issues.
Cancer
The majority of cases of cancer occur in patients over the
age of 65. Cancer rates increase sharply with age in both
sexes: the incidence of cancer is 12–36 times higher in
individuals aged 65 years or older than in individuals
aged 25–44 years, and 2–3 times more common than in
persons aged 45–64 years. It is worth noting that 70% of
deaths attributable to all forms of cancer occur in men and
in women aged 65 years or older, whereas 35% cancer
deaths in men and 46% of cancer deaths in women
occurred in those aged 75 years or older. The relationship
between ageing and cancer is similar for most forms of
cancer, and it is well described by the multistage model of
carcinogenesis. Therefore ageing might be considered not
as a determinant of cancer per se, but as a surrogate marker
of the duration of exposure to relevant carcinogenic fac-
tors [1]. On the other hand the relationship between can-
cer and inflammation have recently been revised and it
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has been suggested that the inflammatory cells and
cytokines found in tumours are more likely to contribute
to tumour growth and progression [2]. Moreover cancer
susceptibility and severity may be associated with func-
tional polymorphisms of inflammatory cytokine genes
[1]. If genetic damage is the "match that lights the fire" of
cancer, some types of inflammation may provide the "fuel
that feeds the flames" [2]. Thus, the increased frequencies
of cancer in ageing might be due to well-known pro-
inflammatory status of ageing [3].
In the Symposium, the role of oncogenes in human cancer
was highlighted by analysing human epithelial thyroid
tumours deriving either from follicular or from parafollic-
ular (C) cells. Follicular-cell derived tumours represent a
wide spectrum of lesions, ranging from benign adenomas
through differentiated, papillary and follicular carcino-
mas, and undifferentiated, anaplastic, carcinomas, thus
providing a good model for finding a correlation between
specific genetic lesions and histologic phenotype. Follicu-
lar adenomas frequently show the presence of mutations
in one of the three ras genes, HRAS, KRAS, and NRAS. G
stimulatory protein (gsp) and thyrotropin receptor (TSH-
R) mutations are at the origin of hyperfunctioning benign
tumours (toxic nodules and adenomas). The two different
types of differentiated thyroid carcinomas exhibit not
only different morphology, but also different behaviour
and are associated with mutations in different oncogenes:
papillary carcinoma with rearrangements of either the
RET or TRK genes and follicular carcinomas with muta-
tions of one of the three ras oncogenes. The p53 tumour
suppressor gene is frequently associated with anaplastic
thyroid carcinomas. RET  is a paradigmatic example of
how different mutations of a single gene can lead to dif-
ferent neoplastic phenotypes. Somatic rearrangements,
often caused by chromosomal inversions, activate the
oncogenic potential of RET in human thyroid papillary
carcinomas. These lesions occur in almost 50% of papil-
lary cancers and consist in the juxtaposition of the 3' tyro-
sine kinase domain of the RET gene which codes for a
receptor protein not normally expressed in follicular cells
with the 5' domain of ubiquitously expressed genes, giv-
ing rise to several types of RET/PTC, papillary thyroid car-
cinomas, chimeric genes. Such ubiquitously expressed
genes provide the promoter and dimerization functions,
necessary for the constitutive activation of RET/PTC pro-
teins. RET germline point mutations are responsible of
familial multiple endocrine neoplasia type 2 syndromes
(MEN 2) represented by (a) Familial Medullary Thyroid
Carcinoma (FMTC), (b) MEN2A and (c) MEN2B, a com-
mon feature of which is the medullary thyroid carcinoma,
a malignant tumour derived from parafollicular C-cells.
RET point mutations can also occur as a somatic event in
sporadic medullary thyroid carcinomas and pheochromo-
cytomas. The detailed knowledge of the specific RET
mutations responsible for human thyroid tumours pro-
vides relevant tools for the clinical management of these
diseases [4,5].
Immunosenescence
In the elderly, many alterations in innate and acquired
immunity have been described and viewed as deleterious,
hence the term immunosenescence. On the other hand,
immunosenescence is a complex process involving multi-
ple re-organisational and developmentally regulated
changes, rather than simple unidirectional decline of the
whole function. However, some immunological parame-
ters are often reduced significantly in the elderly and, vice
versa good function is tightly correlated to health status.
Recent observations indicate that immunosenescence is
not accompanied by an unavoidable and progressive dete-
rioration of the immune function, but is rather the result
of a remodelling where some functions are reduced while
others remain unchanged or are even increased. Impor-
tantly, age-related changes of the immune system are
directly or indirectly involved in the well-known suscepti-
bility of the elderly to infectious diseases, autoimmunity,
and cancer and in the decreased responsiveness to vacci-
nation. The same is true for the pathogenesis of the more
relevant age-related diseases, such as cardiovascular and
neurodegenerative diseases, diabetes, and osteoporosis.
In fact, all these diseases share an important immune
component implicated in their pathogenesis. In addition
it appears that the innate compartment of the immune
system is relatively well preserved during ageing in com-
parison to the more recent and sophisticated clonotypic
compartment that exhibits more profound modifications
[3,6-8].
Senescence of clonotypic immunity is mostly the result of
alterations to T cells. Lifelong chronic antigen load seems
to be the major driving force of immunosenescence,
which impacts on human lifespan by reducing the
number of virgin, i.e. antigen-non experienced, T cells,
and simultaneously fills the immunological space with
expanded clones of memory and effector, i.e. antigen-
experienced, T cells [9]. Such lifelong and chronic antigen
load is responsible for the chronic inflammatory status
that characterises ageing [3]. The progressive reduction of
naïve T cells involving both CD4+ and CD8+ T lym-
phocytes is paralleled by a concomitant increase of mem-
ory CD28- T cells expressing a senescent phenotype, i.e.
progressive shortening of telomeres and reduced replica-
tive capacity [10]. A second fundamental aspect of immu-
nosenescence is the progressive age-related increase of a
proinflammatory status represented by an increase of
inflammatory cytokines and of inflammatory markers
predictive of mobility and mortality [11,12]. This pro-
inflammatory condition is referred to chronic antigenic
load (bacteria, virus, fungi, toxins, mutated cells) thatImmunity & Ageing 2007, 4:4 http://www.immunityageing.com/content/4/1/4
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continuously stimulate innate immunity and seems to
favour the onset of typical age-related diseases (athero-
sclerosis, dementia, osteoporosis, neoplasia) where
immune and autoimmune factors play an important role
[3].
It has been suggested that chronic viral antigenic stimula-
tion could be responsible of age-related modifications of
lymphocyte subsets including clonal expansion of viral
antigen-specific CD8+ T cells expressing a memory phe-
notype and that can represent up to a quarter of the whole
CD8+ T cell population [13]. In a recent study [14], fre-
quencies and phenotype of CD8+ T cell have been evalu-
ated in nonagenarians and centenarians by HLA-A2 and
B7 tetramers that incorporated epitopes specific for
Epstein-Barr Virus (EBV) and Cytomegalovirus (CMV).
The data demonstrate that EBV and CMV induce quantita-
tively and qualitatively different CD8+ T cell responses in
advanced age. The frequency and absolute number of
CD8+ T cells specific for three EBV-epitopes were rela-
tively low and mostly included within CD8+CD28+ cells.
By contrast, CMV infection was characterised by variable
numbers of CD8+ T cells specific for two CMV epitopes
that, in some subjects, were strikingly expanded and did
not express the CD28 molecule. In order to further clarify
the roles of CMV infection and the host, 121 subjects aged
25–100 were recently studied: 18 subjects were seronega-
tive and 103 seropositive for CMV infection. It was
observed that the age-dependent reduction of naïve CD8+
T cells was accelerated in CMV+ subjects while the decline
of naïve CD4+ T cells was not modified by the CMV infec-
tion. The reduction of naïve CD8+ cells was accompanied
by a progressive increase of effector CD8+CD28- cells par-
ticularly in CMV+ subjects. An age-dependent accumula-
tion of CD4+CD28- cells was only observed in CMV+
subjects while these cells were virtually absent within
CMV- subjects. Samples of peripheral blood mononuclear
cells were stimulated with mixtures of peptides spanning
the entire pp65 and IE-1 CMV protein and thereafter the
responding cells, Interferon(IFN)-γ+, were recorded both
among CD8+ and CD4+ T cells. At the functional level, an
age-dependent accumulation of CMV-specific (IFN-γ+)
CD8+ cells was observed while an increase of pp65-spe-
cific CD4+ cells was only observed within subjects over 85
years of age. The majority of CMV-specific CD8+ (IFN-γ+)
and 25% of CD4+ (IFN-γ+) expressed the cytotoxic
degranulation marker CD107a (Sansoni et al., paper sub-
mitted). These data support the view that chronic CMV
infection is responsible for profound modifications of the
lymphocyte subsets not only involving CD8+ but also
CD4+ T cells and probably concurring to the age-depend-
ent proinflammatory status that accompanies the main of
age-associated diseases.
The study of the human immune response in healthy eld-
erly donors has shown that immunosenescence not only
affects the T cell response, but also various aspects of
innate immunity, and probably the most extensive studies
on age associated alterations in the innate immune system
have been directed toward Natural Killer (NK) cells. NK
cells, together with polymorphonuclear cells and macro-
phages, are components of the natural immune system.
They represent a primary host defence system because
they are responsible for spontaneous killing of certain
tumour cells and of virally infected cells. NK cells lack T
cell receptors and are characterised by the membrane
expression of CD56 and CD16. In addition, they display
two alternative mechanisms of cytolysis: a direct sponta-
neous cytotoxicity against a variety of tumour cells and
indirect Fc receptor-mediated cytotoxicity against anti-
body-coated targets (Antibody-Dependent Cell-mediated
Cytotoxicity; ADCC). [15]. A balance of signals received
from multiple activating and inhibitory receptors regu-
lates their effector functions. These receptors allow NK
cells to rapidly survey their environment for potentially
dangerous cells. When an imbalance in signalling favours
activation, secretion of cytokines and/or release of cyto-
toxic granules occurs. In humans, NKG2D is one of the
activating receptors that is expressed on NK cells, Tγδ cells,
and CD8αβ T cells. NKG2D recognises as ligands UL16-
binding protein 1 (ULBP1), ULBP2, ULBP3, ULBP4, and
the MHC class I chain-related molecules, MICA and
MICB. These NKG2D ligands are generally absent or
expressed at low levels on most healthy cells, but can be
induced by viral and bacterial infections. Several studies
have focused on the ability of NK cells to regulate
acquired immune responses through the production of
Th1-type cytokines early during infection or through the
activation of dendritic cells. In addition, by establishing
co-cultures of NK- and antigen-activated T cells, it has
been shown that human NK cells can be induced to
secrete IFN-γ in response to Interleukin(IL)-2 produced by
activated T cells. In contrast, much less has been reported
about the physical interactions that may take place
between NK cells and immune cells of acquired branch of
the response, in particular CD4+ T cells. NK cells promote
acquired immune responses through their production of
type 1 and type 2 cytokines or chemokines. Secretion of
these factors by activated NK cells influences the differen-
tiation of B and T lymphocytes. Increasing evidence indi-
cates that NK cells are also directly involved in dendritic
cell maturation. By contrast, a potential role for direct cell-
cell interactions between NK and T lymphocytes, in partic-
ular CD4+ T cells, has not been explored. It has provided
evidence that activated human NK cells are able of pro-
moting TCR-dependent proliferation of resting autolo-
gous peripheral blood CD4+ T cells by a process that
involves co-stimulatory molecules of the immunoglobu-
lin and tumour necrosis factor (TNF) superfamilies. TheseImmunity & Ageing 2007, 4:4 http://www.immunityageing.com/content/4/1/4
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findings suggest a novel link between natural and
acquired immune responses [16,17].
In 1987 a quantitative analysis of cells expressing the NK
phenotype demonstrated that circulating NK cells
increase in the peripheral blood of healthy individuals
over 70 years old, compared to young or middle-aged
people [18]. The increase in NK cell numbers in the
peripheral blood from elderly people is directly correlated
with age and with a decreased number of T cells support-
ing the idea of a compensative increase in NK cells for a
decreased cytolytic activity. The cytolytic activity displayed
by peripheral blood lymphocytes must be roughly
dependent on the relative proportion of the NK cells
present in the sample. By contrast the cytolytic activity of
NK cells following incubation with K562 cells was found
to be similar between the elderly, extremely healthy sub-
jects selected according to the SENIEUR protocol and
young subjects, despite the twofold increased number of
effector cells [18]. In any case, purified or cloned popula-
tions of NK cells showed a decreased cytolytic activity in
the aged on a per cell basis. This was consistent with the
finding that, following target binding, each CD16-posi-
tive cell from elderly donors exerts only about half of the
cytolytic activity displayed by NK cells from young donors
[19]. However, neither the binding of effector to target
cells nor the effector cells content, distribution or utilisa-
tion of perforin were significantly different between
young and old groups. Therefore some other factors must
account for the decreased lytic activity found in NK cells
from aged people. In fact, the ability of NK cells to trans-
form a receptor-mediated signal into an effector response,
which is linked to the ability to generate second messen-
gers after K562 stimulation, does show a pronounced age-
related decrease. The major biochemical defect appears to
be an age-related delay in PIP2 hydrolysis and decrease in
the levels of IP3 formation in old NK cells after K562 stim-
ulation [20]. Since an essentially preserved density of sur-
face receptors involved in recognition and adhesion on
NK cells was observed during ageing and also a preserved
ability of NK cells to form conjugates with target cells, sig-
nal transduction may be impaired at a step distal to the
binding of receptors.
Increasing evidence has demonstrated that the immune,
endocrine and nervous systems are closely integrated and
communicate through circulating cytokines, hormones
and neurotransmitters. Many hormones and micronutri-
ents have an important influence on the homeostasis of
the immune system and in maintaining the integrity of
body composition. The age-related decrease in adipose
tissue, muscle and bone mass together with an increased
risk of malnutrition, vitamin and trace element deficiency
are among the major factors implicated in the develop-
ment of frailty syndromes and impaired resistance to
infections in the elderly. NK cell number and cytolytic
activity were significantly associated with serum concen-
trations of vitamin D, and this association was consistent
with the evidence that vitamin D supplementation in eld-
erly subjects in vivo significantly modulated NK activity,
increasing circulating levels of IFN-α. Anthropometric
parameters indicating fat reserves and muscle reserves
were also directly correlated with NK cell number and
activity, and fat indicators were linked to vitamin D [21].
A further remarkable finding is the strong correlation
between the number of NK cells and serum concentra-
tions of zinc, a key element in many homeostatic
responses of the body, including oxidative stress and in
many biological functions, including immune efficiency
[22]. In addition, zinc-aspartate supplementation in sub-
jects with low or borderline normal circulating zinc levels
increased concentration of this ion and was able to up-
modulate NK cytolytic activity (Mariani, unpublished
observations), suggesting a conversion of the pro-inflam-
matory status (characterised by high levels pro-inflamma-
tory cytokines and possibly chemokines) [23] into more
balanced Th1/Th2 responses. Because of the close correla-
tion between the degree of malnutrition and immunode-
ficiency in the elderly (increasing the risk of infection, as
demonstrated by the high number of non-responders
among undernourished aged subjects who received influ-
enza vaccination), these results stress the paramount
importance of nutritional evaluation in the clinical assess-
ment of elderly people ([24], for an extensive review).
Age-related inflammatory disease
The individual rates of ageing for the whole organism or
for any organ system may vary, depending on genetics,
disease history, chance, etc. This is especially true for the
immune system. Impaired homeostasis and function of
the immune system (especially of the CD4+ lymphocytes
as the hub immune cells) underlies or at least participates
in the pathology of Alzheimer's disease (AD) and of rheu-
matoid arthritis (RA). Both diseases belong to those that
accelerate ageing (shorten the lifespan) of the sufferers.
The question arising is therefore if the CD4+ cells of RA
and/or AD patients undergo an accelerated ageing them-
selves. The major functionalities of the CD4+ lymphocytes
are manufacturing of multitude of cytokines and periodi-
cal proliferation to make effector and memory clones. The
CD4+ lymphocytes of RA patients are already known to
exhibit certain features similar to those observed for these
cells in the healthy elderly, including relatively short tel-
omeres, decreased amount of surface CD28, decreased
overall proliferation etc. To investigate the possibility of
accelerated aging of CD4+ lymphocytes of RA and AD
patients, a new flow-cytometric technique of studying
lymphocyte proliferation has been utilised. This tech-
nique is, based on staining with Carboxyfluorescein Suc-
cinimidyl ester and extensive mathematical analysis ofImmunity & Ageing 2007, 4:4 http://www.immunityageing.com/content/4/1/4
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acquired data, that allows for better quantification of pro-
liferating lymphocytes, as well as calculation of dynamic
parameters of proliferation including the timing of the
cycle itself and of the G0→ G1 transition time. It allowed
to show that CD4+ cells of RA patients (especially younger
ones) do not differ in these respects form those of healthy
elderly, corroborating with the idea of their accelerated
ageing. At least one of these parameters (the length of the
G0→ G1 transition phase) seems to be correlated with the
level of CD28 expression of the lymphocytes' surface
which, in turn, depends on the regulatory activity of the
proinflammatory cytokine TNF. Also another gene,
Klotho) (sometimes dubbed the 'ageing hormone') con-
tains a putative TNF-responsive regulatory sequence. Fol-
lowing this trace it has been demonstrated that both the
transcriptional activity of the gene and the cellular con-
tents of Klotho protein is greatly reduced in the CD4+ cells
of RA patients regardless from their chronological age,
and similar to that seen in the cells of healthy elderly.
Expectedly, an enzymatic β-glucuronidase activity
ascribed to Klotho protein (supposedly involved in the
hydrolysis of steroid glucuronides) is reduced in both the
RA and healthy elderly CD4+ lymphocytes, which may
participate in the pro-inflammatory status of both elderly
and the RA patients [25,26]. Using the same methodology
for the CD4+  cells of AD patients the quasi-opposite
change was found. Namely, these lymphocytes show the
values of the dynamic parameters of proliferation in vitro,
including the cell cycle and the G0 G1 time resembling
these of the cells from healthy young individuals, despite
being drawn from typical, elderly AD sufferers. Appar-
ently, the exposure to β-amyloid peptides seems to play
the role in these different results obtained for AD cells,
especially the numbers of divisions, proliferation index
and the G0→ G1 time; interestingly, the CD4+ cells of AD
patients seem to react to the peptides more than these of
healthy ones, suggesting possible role of different genetic
background (the HLA?) as one of the reasons for differ-
ence. In summary, these data show that RA may be con-
sidered a case for accelerated aging of the CD4+
lymphocytes, while AD is not, although AD lymphocytes
do display a deviation from normal function (Witkowski,
unpublished observations).
DNA repair
Half a century ago, when the free radical theory of aging
was first proposed, the damaging effects of reactive oxygen
species (ROS) were in the focus of attention and consid-
ered the single most important determinant of aging. Two
decades later, however, the disposable soma theory of age-
ing redirected the attention to the potential impact of cel-
lular maintenance and repair pathways that are both
genetically and environmentally determined and are
counteracting the damaging effects of ROS. In this context
poly(ADP-ribosyl)ation, a DNA-damage driven posttrans-
lational modification of proteins, is of particular interest.
Poly(ADP-ribosyl)ation is catalysed by poly(ADP-ribose)
polymerase-1 (PARP-1), with NAD+ serving as substrate
[27]. PARP-1 activation is triggered by DNA strand breaks,
is functionally associated with DNA repair pathways and
is a survival factor for cells under low to moderate levels
of genotoxic stress. Over a decade ago, a positive correla-
tion between poly(ADP-ribosyl)ation capacity of mono-
nuclear blood cells with longevity of mammalian species
was described [28]. The subsequent comparison of puri-
fied recombinant human and rat PARP-1 revealed that
this correlation might be explained in part by evolution-
ary sequence divergence [29]. This view fits perfectly with
recent results from the literature on different knockout
mice defective for nucleotide excision repair genes, reveal-
ing a crucial role of DNA repair as a longevity assurance
pathway. In order better to understand the role of DNA
repair and of poly(ADP-ribosyl)ation in ageing, the
Bürkle group has recently developed an improved method
to quantify DNA strand breaks and DNA crosslink forma-
tion in living cells by an automated fluorescence-detected
alkaline DNA unwinding (FADU) assay. They have also
set up a new assay to monitor poly(ADP-ribose) forma-
tion in living cells by flow cytometry, based on an assay
previously developed for permeabilised cells [30].
Longevity
The improvements of the social-environmental condi-
tions, of medical care, and the quality of life caused a gen-
eral improvement of the health status of the population
and a consequent reduction of the overall morbidity and
mortality, resulting in an overall increase of life expect-
ancy. Around the 1970s, the progressive decline of mortal-
ity (1–2% per year) in individuals over 80 years old has
increased in all industrialized countries, so that the
number of centenarians has augmented about 20-fold.
Centenarians represent a cohort of select survivors who
benefit from a delay in the onset of diseases that often
cause mortality in the general population at significantly
younger ages [31]. A body data collected on the genetics
of human longevity, mostly resulting from studies on cen-
tenarians, indicates that the following: Centenarians and
long-living sibpairs are a good choice for the study of
human longevity, because they represent an extreme phe-
notype, i.e. the survival tail of the population who escaped
neonatal mortality, pre-antibiotic era illnesses, and fatal
outcomes of age-related complex diseases. The model of
centenarians is not simply an additional model with
respect to well-studied organisms, and the study of
humans has revealed characteristics of ageing and longev-
ity (geographical and gender differences, role of antigenic
load and inflammation, role of mtDNA variants) which
did not emerge from studies in animal model systems. All
the phenotypic characteristics of nonagenarians and cen-
tenarians fit the hypothesis that ageing is a remodellingImmunity & Ageing 2007, 4:4 http://www.immunityageing.com/content/4/1/4
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process where the body of survivors progressively adapts
to internal and external damaging agents they are exposed
to during several decades, largely unpredicted by evolu-
tion. Such a remodelling process, which can be consid-
ered a Darwinian process occurring at the somatic level
within the framework of the evolutionary constraints
established by evolution for H. sapiens as a species may
explain why the same gene polymorphism can have dif-
ferent (beneficial or detrimental) effects at different ages.
Demographic evidence suggests that longevity can be
achieved by different combinations of genes, environ-
ment, and chance, in a pattern that may be quantitatively
and qualitatively different in different geographic areas,
and that population-specific genetic factors play a role in
the longevity phenotype. The concomitant and integrated
use of new in silico and high-throughput strategies will
greatly accelerate the identification of new longevity genes
in humans [32-36,3].
There is a widespread consensus that the existence of a
greater or a lesser number of centenarians largely depends
on mortality features between 80 and 100 years of age. In
fact, lower mortality among this age group implies that
more people should live until they are aged 100 or over.
Hence, demographers apply an indicator of mortality
between 80 and 100 years in order to define the longevity
of a population and not, as is done elsewhere, the propor-
tion of centenarians in the population. Sardinia, two sec-
ond largest island of Italy, has drawn widespread interest
because of the large number of centenarians and the exist-
ence of a geographical area where male mortality after 80
years is lower than anywhere else in the region and Italy
Mortality in Sicily after age of 80 years: Male (left) Female (right) period 1994–2001 (low mortality in blue, high mortality in  red) Figure 1
Mortality in Sicily after age of 80 years: Male (left) Female (right) period 1994–2001 (low mortality in blue, high mortality in 
red). For women in blue area the mortality is higher than in Italy. The municipalities concerned do not include polluted areas 
and are small, with the lowest number of inhabitants.Immunity & Ageing 2007, 4:4 http://www.immunityageing.com/content/4/1/4
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[37,38]. This area covers various municipalities in the cen-
tre of the island, to the south of the province of Nuoro,
where male mortality from cardiovascular diseases and
cancers is especially low [39]. Focussing on genetically
isolated populations, who are more homogeneous than
the overall population with respect to cultural and histor-
ical background, origin and demographic parameters, is
considered the most promising tool for the analysis and
mapping of continuous multifactorial traits [40]. Once
having seen the interesting outcome for Sardinia, it has
turned focus to the largest island, Sicily, to see if some-
thing similar exists. The first aim was to identify geo-
graphic areas that are homogeneous with regard to low
mortality of men and women after age 80 and to investi-
gate the region-specific causes of death after this age. The
second aim was to compare Sicily and Sardinia to see if
there are some analogies and to find an explanation. Ref-
erence periods were 1981–1990 and 1991–2001. The
2001 census reports 390 municipalities in Sicily and 377
in Sardinia. The 386 and 363, respectively, selected here
are geographically similar at the starting date of the
municipal analysis (1981). Standardized mortality ratios
(SMR) were calculated by municipalities (for all-cause
and specific cause mortality) for ages 80 and over accord-
ing to procedures applied in epidemiology. The Kernel
density estimator is used to construct geographical maps.
Kernel density estimators are the smoothed SMRs
obtained as the spatial moving average for a number of
municipalities adjacent to a given municipality. Results
obtained highlight an area of longevity for men but not
for women in Sicily with similar features to those found in
Sardinia (Figure 1). In both cases the municipalities con-
cerned do not include polluted areas and are small, with
the lowest number of inhabitants. So, longevity concerns
men living in a small town, without pollution, likely
because of different working conditions, different life style
i.e. reduced smoking and alcohol abuse and Mediterra-
nean diet. Accordingly, these areas both in Sicily and in
Sardinia also share low mortality from cancers and cardi-
ovascular diseases. (Caselli & Lipsi, unpublished observa-
tions). Longevity is reduced for women likely because of
different women condition and different educational
level which produce a different access to prevention or to
health facilities. The reason because longevity has been
observed particulary in small municipalities is not surpris-
ing. It is well established, in fact, that individuals with
greater access to social support and family network have
better health and lower levels of mortality, particularly
when adult daughters are present.
Conclusive remarks
To conclude, ageing must be considered an unavoidable
end point of the life history of each individual, neverthe-
less the increasing knowledge on ageing mechanisms,
allows envisaging many different strategies to cope with,
and delay it. So, a better understanding of pathophysiol-
ogy of ageing and age-related disease is essential for giving
everybody a reasonable chance for living a long and
enjoyable final part of the life.
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